Advances in liquid biopsy technology - IMAT spotlight: Dr. Shana Kelley

Advances in liquid biopsy technology - IMAT spotlight: Dr. Shana Kelley

10/08/2019

Dr. Shana Kelley is an IMAT-supported investigator from the University of Toronto. The IMAT grant program supports the development of novel technologies to further cancer research. Here, Dr. Kelley describes the progress of her group's novel technology platform MagRC, which is advancing the new field of liquid biopsies for clinical care of cancer patients. This video is a testimonial from an IMAT-supported researcher that serves to highlight a success story from the program. imat.cancer.gov/about-imat/outputs-and-achievements/success-stories/liquid-biopsy-3-magnetic-ranking-cytometry-magrc imat.cancer.gov/about-imat/outputs-and-achievements/success-stories